Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply 'hyperfibrinolysis'.
作者信息
Hardy M, Bareille M, Lecompte T, Mullier F
机构信息
Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Hematology Laboratory, Yvoir, Belgium.
Université de Lorraine, Nancy, France; Université de Namur, Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium.
出版信息
Thromb Res. 2022 Jun;214:63-64. doi: 10.1016/j.thromres.2022.04.012. Epub 2022 Apr 25.
Abstract
摘要
相似文献
1
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply 'hyperfibrinolysis'.
Thromb Res. 2022 Jun;214:63-64. doi: 10.1016/j.thromres.2022.04.012. Epub 2022 Apr 25.
2
Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations.
PLoS One. 2019 Nov 14;14(11):e0225089. doi: 10.1371/journal.pone.0225089. eCollection 2019.
3
Association between ascites and primary hyperfibrinolysis: A cohort study in 210 dogs.
Vet J. 2017 May;223:12-20. doi: 10.1016/j.tvjl.2017.03.008. Epub 2017 Mar 31.
4
A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Br J Haematol. 1990 Apr;74(4):471-9. doi: 10.1111/j.1365-2141.1990.tb06337.x.
5
D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.
J Clin Lab Anal. 2003;17(3):77-9. doi: 10.1002/jcla.10072.
6
7
Is it possible to make a common reference standard for D-dimer measurements? Communication from the ISTH SSC Subcommittee on Fibrinolysis.
J Thromb Haemost. 2022 Feb;20(2):498-507. doi: 10.1111/jth.15555. Epub 2021 Nov 24.
8
Characterization of fibrin/fibrinogen degradation products reagents and their utility in critical care patients with enhanced fibrinolysis.
Int J Lab Hematol. 2021 Aug;43(4):813-820. doi: 10.1111/ijlh.13428. Epub 2020 Dec 10.
9
Coagulation and fibrinolysis disorder in muscular dystrophy.
Muscle Nerve. 2001 Mar;24(3):399-402. doi: 10.1002/1097-4598(200103)24:3<399::aid-mus1012>3.0.co;2-b.
10
Coagulopathy and Traumatic Brain Injury: Overview of New Diagnostic and Therapeutic Strategies.
Neurol Med Chir (Tokyo). 2022 Jun 15;62(6):261-269. doi: 10.2176/jns-nmc.2022-0018. Epub 2022 Apr 22.
引用本文的文献
1
Utility of fibrinolysis enhanced viscoelastic assays to evaluate fibrinolysis disorders in critically ill adults with severe infection: a scoping review.
Ann Intensive Care. 2025 Jul 31;15(1):110. doi: 10.1186/s13613-025-01528-x.
2
Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19.
J Clin Med. 2023 Jan 11;12(2):601. doi: 10.3390/jcm12020601.
3
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study.
Thromb J. 2022 Aug 29;20(1):48. doi: 10.1186/s12959-022-00403-0.
本文引用的文献
1
Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?
Thromb Res. 2022 Feb;210:1-3. doi: 10.1016/j.thromres.2021.12.012. Epub 2021 Dec 20.
2
Could Daily Monitoring of Fibrin Related Markers Help Suspect a Thrombotic Event in COVID-19 Patients? A Prospective Pilot Study.
TH Open. 2021 May 12;5(2):e152-e154. doi: 10.1055/s-0041-1728722. eCollection 2021 Apr.
3
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review.
J Clin Med. 2021 Apr 16;10(8):1740. doi: 10.3390/jcm10081740.
4
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
Thromb Res. 2021 Jan;197:20-23. doi: 10.1016/j.thromres.2020.10.025. Epub 2020 Oct 24.
5
Histopathological observations in COVID-19: a systematic review.
J Clin Pathol. 2021 Feb;74(2):76-83. doi: 10.1136/jclinpath-2020-206995. Epub 2020 Aug 18.
6
All those D-dimers in COVID-19.
J Thromb Haemost. 2020 Aug;18(8):2075-2076. doi: 10.1111/jth.14939. Epub 2020 Jun 25.
7
Defining trauma-induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH.
J Thromb Haemost. 2020 Mar;18(3):740-747. doi: 10.1111/jth.14690.
8
The current status of viscoelastic testing in septic coagulopathy.
Thromb Res. 2019 Nov;183:146-152. doi: 10.1016/j.thromres.2019.09.029. Epub 2019 Oct 23.
9
Review of D-dimer testing: Good, Bad, and Ugly.
Int J Lab Hematol. 2017 May;39 Suppl 1:98-103. doi: 10.1111/ijlh.12665.
10
Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.
Thromb J. 2016 Jan 14;14:1. doi: 10.1186/s12959-016-0076-2. eCollection 2016.
Zotero 插件